Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Bremer

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Hepatology Communications|February 7, 2018
Hepatitis E virus replication and interferon responses in human placental cellsLeonard Knegendorf, Svenja A Drave, Viet Loan Dao Thi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2020
Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II studyBirgit Bremer, Olympia E Anastasiou, Svenja Hardtke, et al.
Pancreas|January 20, 2016
Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic PancreatitisBastian Schönemeier, Jochen Metzger, Julie Klein, et al.
Journal of Hepatology|January 27, 2022
Hepatitis E virus is highly resistant to alcohol-based disinfectantsPatrick Behrendt, Martina Friesland, Jan-Erik Wißmann, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 30, 2009
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipientsSven Pischke, Pothakamuri V Suneetha, Christine Baechlein, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis DLisa Sandmann, Mathias Jachs, Tammo L Tergast, et al.
Journal of Hepatology|July 19, 2011
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantationIngmar Mederacke, Natalie Filmann, Cihan Yurdaydin, et al.
Journal of Viral Hepatitis|November 13, 2020
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reductionOlympia E Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, et al.
Plos One|July 30, 2014
Anti-HDV IgM as a marker of disease activity in hepatitis deltaAnika Wranke, Benjamin Heidrich, Stefanie Ernst, et al.
Gut|April 15, 2026
CD16<sup>+</sup> γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infectionPaulina E Schröter, Katja Steppich, Laura Fernández Carrera, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Hepatology Communications|February 7, 2018
Hepatitis E virus replication and interferon responses in human placental cellsLeonard Knegendorf, Svenja A Drave, Viet Loan Dao Thi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2020
Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II studyBirgit Bremer, Olympia E Anastasiou, Svenja Hardtke, et al.
Pancreas|January 20, 2016
Urinary Peptide Analysis Differentiates Pancreatic Cancer From Chronic PancreatitisBastian Schönemeier, Jochen Metzger, Julie Klein, et al.
Journal of Hepatology|January 27, 2022
Hepatitis E virus is highly resistant to alcohol-based disinfectantsPatrick Behrendt, Martina Friesland, Jan-Erik Wißmann, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 30, 2009
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipientsSven Pischke, Pothakamuri V Suneetha, Christine Baechlein, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis DLisa Sandmann, Mathias Jachs, Tammo L Tergast, et al.
Journal of Hepatology|July 19, 2011
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantationIngmar Mederacke, Natalie Filmann, Cihan Yurdaydin, et al.
Journal of Viral Hepatitis|November 13, 2020
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reductionOlympia E Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, et al.
Plos One|July 30, 2014
Anti-HDV IgM as a marker of disease activity in hepatitis deltaAnika Wranke, Benjamin Heidrich, Stefanie Ernst, et al.
Gut|April 15, 2026
CD16<sup>+</sup> γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infectionPaulina E Schröter, Katja Steppich, Laura Fernández Carrera, et al.
Pageof 7